DATA GRAPHICS | Finance
Corporate venture investments by modality: Data Byte
Corporate VCs are beginning to invest in newer modalities, but small molecules still dominate
July 21, 2021 11:56 PM UTC
While companies working on established modalities including small molecules, mAbs and proteins comprised more than half of venture rounds backed by corporate VCs last year, this subset of investors is also beginning to dip its toes into newer modalities. ...